Lupus & Pregnancy Virtual Clinic
A no-cost, online lupus educational for rheumatologists and non-rheumatology providers, specifically those who work with patients who are of child-bearing age.
Based on the 2020 ACR Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases, this case allows you to work with a new patient living with lupus as she navigates multiple appointments and changes to her reproductive health and childbearing timeline. Utilizing information about her lupus history, decide which forms of contraception are recommended before pregnancy and whether to modify medications during pregnancy and post-partum. Complete the case by deciding next steps for treating the patient.
With the Lupus & Pregnancy Virtual Clinic, you receive:
- One case
- Multiple-choice questions
- Image and educational links
- Up to 1.00 ABIM MOC points and 1.0 AMA PRA Category 1 Credit(s)™ with a passing score of 70% or higher
Rheumatologists, non-rheumatology physicians, physician assistants, and nurse practitioners. This case will be especially beneficial for nurse practitioners, physician assistants, OB-GYNs, primary care physicians, endocrinologists, pharmacists, midwives and doulas, and others who work with patients who are trying to conceive, are currently pregnant, or have recently given birth (and their partners).
Upon completion of this activity, participants should be able to do the following:
- Recognize that a woman with lupus who is healthy and whose lupus has been under control for at least six months may have a safe and successful pregnancy
- Describe how antiphospholipid antibody status influences the selection of a safe and effective form of contraception for a woman with lupus who is seeking to prevent pregnancy
- Explain why hydroxychloroquine should be continued throughout pregnancy
- Describe potential adverse pregnancy outcomes associated with anti-Ro/SSA and anti-La/SSB antibodies
- Recognize that women with lupus have a higher risk of flare post-partum
- List possible clinical signs of active lupus and describe how one would perform a laboratory evaluation for active lupus
- Demonstrate successful use and integration of guidelines into patient care decisions
Registration is complimentary.
CME and MOC Information
The American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The ACR designates this online activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By completing this activity you provide the ACR permission to share completion data with the ACCME and the certifying board(s).
Faculty and Disclosures
ACR Disclosure Statement
The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. Educational activities provided by the ACR must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias.
Faculty participating in an ACR-sponsored activity must disclose to the editorial team and audience any financial or other relationship(s) including, but not limited to:
- Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Research grants
- Employment (full or part-time)
- Ownership or partnership
- Consulting fees or other remuneration (payment)
- Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson
- Receipt of royalties
- Speakers' bureau
The faculty reported the following disclosures.
- Sonam Kiwalkar, MD - No relevant financial relationships to disclose
- Karen Law, MD - No relevant financial relationships to disclose
- Janet Jolly, NP-C - No relevant financial relationships to disclose
- Leslie E. Kahl, MD - No relevant financial relationships to disclose
- Julianna Desmarais, MD - No relevant financial relationships to disclose
- Stacey Ardoin, MD, MHS - No relevant financial relationships to disclose
- Angela Boleware, RN, MSN, FNP-C - No relevant financial relationships to disclose
- Lisa Haynie, PhD, RN, CFNP - No relevant financial relationships to disclose
- Anne Norwood, PhD, FNP - No relevant financial relationships to disclose
Acknowledgement of Support
This project was, in part, supported by the Centers for Disease Control and Prevention under Cooperative Agreement Number 6 NU58 DP006138. Its contents are solely the responsibility of its developers/authors. Points of view or opinions do not, therefore, necessarily represent official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.